加强中西医结合防治肝癌的临床研究

刘平

doi:10.3969/j.issn.1001-5256.2016.04.001

加强中西医结合防治肝癌的临床研究

DOI: 10.3969/j.issn.1001-5256.2016.04.001

刘平

上海中医药大学附属曙光医院肝病研究所,上海高校中医内科学E-研究院

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1534
- HTML全文浏览量: 16
- PDF下载量: 426
- 被引次数: 0
出版历程
- 出版日期: 2016-04-20

A clinical analysis of strengthening integrated traditional Chinese and Western medicine therapy for prevention and treatment of liver cancer

Liu Ping

Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine; E-institutes of Shanghai Municipal Education Commission, Shanghai University of Traditional Chinese Medicine

摘要

摘要:
原发性肝癌病死率占据我国恶性肿瘤的第二位,而我国肝癌大多发生在肝硬化基础之上,针对我国原发性肝癌的发病特点,在充分应用西医学有效治疗方法的基础上,发掘中国的医药资源优势,探索具有中国特色的肝癌综合防治方案,有效降低肝癌的发病率与病死率是目前面临的艰巨任务。
- 肝肿瘤 /
- 中西医结合疗法 /
- 述评
Abstract:
Primary liver cancer has the second highest fatality among malignant tumors in China,and in our country,most cases of liver cancer occur on the basis of liver cirrhosis. In view of the clinical characteristics of primary liver cancer in China,we need to make full use of effective therapies in Western medicine,explore the advantages of traditional Chinese medicine,develop unique comprehensive regimens for the prevention and treatment of liver cancer,and effectively reduce the incidence and fatality of liver cancer.
- liver neoplasms /
- TCM WM THERAPY /
- editorial

HTML全文

参考文献(14)

[1]The Ministry of Health of the People's Republic of China.Diagnosis and treatment of hepatocellular carcinoma(V2011)[J].J Clin Hepatol,2011,27(11):1141-1159.(in Chinese)中华人民共和国卫生部.原发性肝癌诊疗规范(2011年版)[J].临床肝肿病杂志,2011,27(11):1141-1159.

[2] Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.

[3]DOU AH,ZHENG JF,LIU H,et al.The study on incidence of primary hepatic carcinoma of liver cirrhosis patients with type 2 diabetes mellitus[J].Beijing Med J,2013,35(6):412-415.(in Chinese)窦爱华,郑俊福,刘晖,等.肝硬化合并2型糖尿病发生原发性肝癌的风险研究[J].北京医学,2013,35(6):412-415.

[4]OKA H,YAMAMOTO S,KUROKI T,et al.Prospective study of chemoprevention of hepatoeellular carcinoma with sho-saiko-to(TJ-9)[J].Cancer,1995,76(5):743-749.

[5]LIU CH,LIU P,HU YY,et al.Progress of clinical and basic research on liver fibrosis with traditional Chinese medicine[J].World Sci Technol Modern Tradit Chin Med,2007,9(2):112-119.(in Chinese)刘成海,刘平,胡义扬,等.中医药抗肝纤维化临床与基础研究进展[J].世界科学技术-中医药现代化,2007,9(2):112-119.

[6]GU J,ZHANG Q,XUE D,et al.A randomized controlled study of fuzheng huayu capsule for prevention of esophageal variceal bleeding in patients with liver cirrhosis[J].Evid Based Complement Alternat Med,2013,2013:534960.

[7]LYU J,WANG Q,TAO Y,et al.The mechanism and active components of fuzheng huayu decoction action against liver fibrosis relating to angiogenesis[J].Hepatology,2011,54(Suppl):749-750.

[8]TANG ZY.My view of improving curative effect of liver cancer[J].Chin J Hepatobiliary Surg,2010,16(8):561-562.(in Chinese)汤钊猷.提高肝癌疗效的我见[J].中华肝胆外科杂志,2010,16(8):561-562.

[9]WANG LH,CAI HZ,LU Y.Meta analysis on difference between the integrated traditional and western treatment and simple Western medicine treatment on patients with advanced primary liver cancer[J].Anti-Tumor Pharm,2011,1(2):144-148.(in Chinese)王理槐,蔡虎志,陆阳.中晚期原发性肝癌中西医结合治疗与西医治疗疗效比较的Meta分析[J].肿瘤药学,2011,1(2):144-148.

[10]QIU YW,LIN LZ,HUANG XW,et al.Influence of Chinese medicine on life span of middle-late primary hepatic carcinoma patients:a multicenter retrospective cohort study[J].J Guangzhou Univ Tradit Chin Med,2014,31(5):699-704.(in Chinese)丘奕文,林丽珠,黄学武,等.多中心回顾性队列研究中医药对中晚期原发性肝癌生存期的影响[J].广州中医药大学学报,2014,31(5):699-704.

[11]YU EX,LIU LM,SONG MZ,et al.Combined moving strip whole liver irradiation and traditional Chinese medicine for large liver cancer[J].Chin J Oncol,1992,14(1):57-59.(in Chinese)于尔辛,刘鲁明,宋明志,等.全肝移动条野放射结合中药治疗大肝癌的临床研究[J].中华肿瘤杂志,1992,14(1):57-59.

[12]XIONG W,REN ZG,QIU SJ,et al.Residual hepalocellular carcinoma after oxaliplatin treatment has increased metastatic potentia Iin a nude mouse model and is attenuated by songyou yin[J].BMC Cancer,2010,10(1):1-11.

[13]YANG YK,QIU DZ,WANG GY,et al.Clinical study on Jiawei Yiguanjian for improvement of the survival rate in advanced hepatocellular carcinoma patients[J].Clin Med J China,2011,18(6):818-820.(in Chinese)杨云柯,仇冬则,王国骅,等.中药加昧一贯煎提高原发性肝癌晚期患者生存率的临床研究[J].中国临床医学杂志,2011,18(6):818-820.

[14]ZHOU YN,MU YP,FU WW,et al.Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice[J].BMC Complement Altern Med,2015,15:342.

施引文献

资源附件(0)

访问统计